Cellular Biomedicine Group, Inc. - FORM 10-Q - EX-32.1 - CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE - May 6, 2020

Attached files

file filename
EX-31.1 - CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF - Cellular Biomedicine Group, Inc.cbmg_ex311.htm
EX-10.1 - MATERIAL CONTRACTS - Cellular Biomedicine Group, Inc.cbmg_ex101.htm
10-Q - QUARTERLY REPORT - Cellular Biomedicine Group, Inc.cbmg_10q.htm
 
Exhibit 32.1
 
CERTIFICATION
 
In connection with the quarterly report of Cellular Biomedicine Group, Inc. (the “Company”) on Form 10-Q for the quarter ended March 31, 2020, as filed with the Securities and Exchange Commission (the “Report”), I, Tony (Bizuo) Liu, Chief Executive Officer and Chief Financial Officer (Principal Executive Officer and Principal Financial and Accounting Officer) of the Company, hereby certify as of the date hereof, solely for purposes of Title 18, Chapter 63, Section 1350 of the United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:
 
(1)           The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, and
 
(2)           The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated.
 
A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request. 
 
 
 
 
 
Date: May 6, 2020
By:
/s/ Tony (Bizuo) Liu
 
 
 
Tony (Bizuo) Liu
 
 
 
Chief Executive Officer and Chief Financial Officer
 
 
 
 (Principal Executive Officer and Principal Financial and Accounting Officer)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Stock widget

Investing forum

Cellular Biomedicine Group, Inc. Reports